 |
|
5-[18F]fluorouracil
The fluorine-18 (18F)-radiolabeled pyrimidine analog 5-fluorouracil (5-FU) with positron-emitting activity. Upon administration, 5-[18F]fluorouracil distribution in tumor tissue may be measured with positron emission tomography (PET). The degree of 5-[18F]fluorouracil uptake in tumor tissue may help to predict the response to 5-fluorouracil-based chemotherapy or to determine the response to other therapeutic agents used to treat 5-FU-sensitive tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Previous: | 3-deazauridine, 4'-iodo-4'-deoxydoxorubicin, 4-hydroxytamoxifen, 4-nitroestrone 3-methyl ether, 5,10-methylenetetrahydrofolate | | Next: | 5-hydroxytryptophan, 50% oxygen/50% nitrous oxide premix, 6-azauridine, 7-cyanoquinocarcinol, 7-hydroxystaurosporine |
|
|
